UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis

Neurochemical research, 2014-10, Vol.39 (10), p.2008-2017

2014

Volltextzugriff (PDF)

Discovery of a Potent, Orally Available, and Isoform-Selective Retinoic Acid β2 Receptor Agonist

Journal of medicinal chemistry, 2005-12, Vol.48 (24), p.7517-7519

2005

Volltextzugriff (PDF)

Constitutively Active Mutants of the Histamine H1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors

Molecular pharmacology, 2008-01, Vol.73 (1), p.94

2008

Volltextzugriff (PDF)

Optimization of isochromanone based urotensin II receptor agonists

Bioorganic & medicinal chemistry, 2010-07, Vol.18 (13), p.4844-4854

2010

Volltextzugriff (PDF)

Identification of novel subtype selective RAR agonists

Biochemical pharmacology, 2005-12, Vol.71 (1), p.156-162

2005

Volltextzugriff (PDF)

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Schizophrenia research, 2012-11, Vol.141 (2), p.144-152

2012

Volltextzugriff (PDF)

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Schizophrenia research, 2012-11, Vol.141 (2-3), p.144-152

2012

Volltextzugriff (PDF)

Stereoselective Epoxidation of Phe-Gly and Phe-Phe Vinyl Isosteres

Journal of organic chemistry, 1994-03, Vol.59 (5), p.1139-1148

1994

Volltextzugriff (PDF)

Discovery of an Ectopic Activation Site on the M 1 Muscarinic Receptor

Molecular pharmacology, 2002-06, Vol.61 (6), p.1297-1302

2002

Volltextzugriff (PDF)

II. In vitro evidence that (−)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors

JOURNAL OF NEURAL TRANSMISSION, 2011-11, Vol.118 (11), p.1523-1533

2011

Volltextzugriff (PDF)

Design, parallel synthesis and SAR of novel urotensin II receptor agonists

European journal of medicinal chemistry, 2007-02, Vol.42 (2), p.276-285

2007

Volltextzugriff (PDF)

Design, Synthesis, and Structure−Activity Analysis of Isoform-Selective Retinoic Acid Receptor β Ligands

Journal of medicinal chemistry, 2009-03, Vol.52 (6), p.1540-1545

2009

Volltextzugriff (PDF)

1 The Chemistry and Biochemistry of C-Nucleosides and C-Arylglycosides

Progress in Medicinal Chemistry, 1985, Vol.22, p.1-65

1985

Volltextzugriff (PDF)

Analysis of molecular determinants of affinity and relative efficacy of a series of R ‐ and S ‐2‐(dipropylamino)tetralins at the 5‐HT 1A serotonin receptor

British journal of pharmacology, 2009-01, Vol.138 (6), p.1129-1139

2009

Volltextzugriff (PDF)

Constitutively Active Mutants of the Histamine H 1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors

Molecular pharmacology, 2008-01, Vol.73 (1), p.94-103

2008

Volltextzugriff (PDF)

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

Journal of medicinal chemistry, 2006-04, Vol.49 (7), p.2232-2240

2006

Volltextzugriff (PDF)

Base-Catalyzed cyclization of N-propargylamides to oxazoles

Journal of heterocyclic chemistry, 1989-03, Vol.26 (2), p.269-275

1989

Volltextzugriff (PDF)

3-Heteroaryl-Substituted Quinuclidin-3-ol and Quinuclidin-2-ene Derivatives as Muscarinic Antagonists. Synthesis and Structure-Activity Relationships

Journal of medicinal chemistry, 1995-02, Vol.38 (3), p.473-487

1995

Volltextzugriff (PDF)

PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain

The international journal of neuropsychopharmacology, 2008-03, Vol.11 (2), p.163-171

2008

Volltextzugriff (PDF)

Isochromanone-based urotensin-II receptor agonists

Bioorganic & medicinal chemistry, 2005-04, Vol.13 (8), p.3057-3068

2005

Volltextzugriff (PDF)

Novel and potent small-molecule urotensin II receptor agonists

Bioorganic & medicinal chemistry, 2009-07, Vol.17 (13), p.4657-4665

2009

Volltextzugriff (PDF)

Synthesis of 1,2,4-Oxadiazole-, 1,3,4-Oxadiazole-, and 1,2,4-Triazole-Derived Dipeptidomimetics

Journal of organic chemistry, 1995-05, Vol.60 (10), p.3112-3120

1995

Volltextzugriff (PDF)

Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches

Journal of medicinal chemistry, 1993-04, Vol.36 (8), p.967-976

1993

Volltextzugriff (PDF)

Atropisomeric Derivatives of 2‘,6‘-Disubstituted (R)-11-Phenylaporphine: Selective Serotonin 5-HT7 Receptor Antagonists

Journal of medicinal chemistry, 2001-04, Vol.44 (9), p.1337-1340

2001

Volltextzugriff (PDF)

Pharmacology of polymorphic variants of the human 5-HT1A receptor

Biochemical pharmacology, 2004-02, Vol.67 (3), p.479-490

2004

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Aktive Filter

ThemaRats

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(117)
Buchkapitel
(2)

Sprache

Englisch
(119)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(44)
Chemistry
(35)
Pharmacology & Pharmacy
(35)
Physical Sciences
(28)
Biological And Medical Sciences
(25)
Chemistry, Medicinal
(24)
Chemistry, Organic
(24)
Animals
(23)
Medical Sciences
(23)
Organic Chemistry
(23)
Pharmacology. Drug Treatments
(21)
Humans
(19)
Exact Sciences And Technology
(18)
Neuropharmacology
(17)
Structure-Activity Relationship
(16)
Preparations And Properties
(15)
Neurotransmitters. Neurotransmission. Receptors
(14)
Guinea Pigs
(10)
Mice
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis

Discovery of a Potent, Orally Available, and Isoform-Selective Retinoic Acid β2 Receptor Agonist

Constitutively Active Mutants of the Histamine H1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors

Optimization of isochromanone based urotensin II receptor agonists

Identification of novel subtype selective RAR agonists

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Stereoselective Epoxidation of Phe-Gly and Phe-Phe Vinyl Isosteres

Discovery of an Ectopic Activation Site on the M 1 Muscarinic Receptor

II. In vitro evidence that (−)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors

Design, parallel synthesis and SAR of novel urotensin II receptor agonists

Design, Synthesis, and Structure−Activity Analysis of Isoform-Selective Retinoic Acid Receptor β Ligands

1 The Chemistry and Biochemistry of C-Nucleosides and C-Arylglycosides

Analysis of molecular determinants of affinity and relative efficacy of a series of R ‐ and S ‐2‐(dipropylamino)tetralins at the 5‐HT 1A serotonin receptor

Constitutively Active Mutants of the Histamine H 1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

Base-Catalyzed cyclization of N-propargylamides to oxazoles

3-Heteroaryl-Substituted Quinuclidin-3-ol and Quinuclidin-2-ene Derivatives as Muscarinic Antagonists. Synthesis and Structure-Activity Relationships

PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain

Isochromanone-based urotensin-II receptor agonists

Novel and potent small-molecule urotensin II receptor agonists

Synthesis of 1,2,4-Oxadiazole-, 1,3,4-Oxadiazole-, and 1,2,4-Triazole-Derived Dipeptidomimetics

Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches

Atropisomeric Derivatives of 2‘,6‘-Disubstituted (R)-11-Phenylaporphine: Selective Serotonin 5-HT7 Receptor Antagonists

Pharmacology of polymorphic variants of the human 5-HT1A receptor

Aktive Filter

Suchergebnisse filtern